ArticleWorld journal of oncology2022

A Novel Cuproptosis-Related Signature Identified DLAT as a Prognostic Biomarker for Hepatocellular Carcinoma Patients.

Wen Dong Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.